Mixed urinary incontinence symptoms: Urodynamic findings, incontinence severity, and treatment response

被引:91
作者
Bump, RG
Norton, PA
Zinner, NR
Yalcin, I
机构
[1] Eli Lilly & Co, Lilly Corp Ctr, Indianapolis, IN 46285 USA
[2] Univ Utah, Dept Obstet & Gynecol, Salt Lake City, UT USA
[3] Doctors Urol Grp, Torrance, CA USA
关键词
D O I
10.1016/S0029-7844(03)00376-4
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the relationship between the symptom of mixed urinary incontinence and incontinence severity, urodynamic findings, and treatment response. METHODS: This is a secondary analysis of data from 553 women randomized into a double-blind, placebo-controlled study evaluating duloxetine (serotonin-norepinephrine reuptake inhibitor) for the treatment of predominant stress urinary incontinence. Assessment variables included incontinent episode frequency, the Incontinence Quality of Life Questionnaire (I-QOL), and the Patient Global Impression of Severity Scale (PGI-S). Urge symptoms were identified with three urge I-QOL questions not included in corrected I-QOL calculations. RESULTS: At baseline, 171 women (31%) had mixed urinary incontinence. They had more severe baseline urinary incontinence than did those with stress urinary incontinence (mean incontinent episode frequency 14.3 versus 10.5; PGI-S normal or mild 26.5% versus 70.4%; mean corrected I-QPL 59.1 versus 79.9; all Ps < .001). Baseline urodynamics were performed on a subset of 86 women. Subjects with both urodynamic stress incontinence and detrusor overactivity had less severe incontinence compared with subjects with only urodynamic stress incontinence. Both mixed urinary incontinence and stress urinary incontinence groups had significant decreases in median incontinent episode frequency at a 40 mg per day (62% and 58%, respectively) and 80 mg per day (63% and 65%) duloxetine dose compared with placebo (33% and 44%; all Ps < .05). Response was not dependent on the type of symptoms (interaction P = .47). CONCLUSION: For women presenting with predominant stress urinary incontinence symptoms, the major determinant of concurrent urge symptoms was incontinence severity and not the pathophysiologic condition(s) causing the incontinence; duloxetine demonstrated equal efficacy for women with mixed urinary incontinence and pure stress urinary incontinence.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 18 条
  • [1] Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
  • [2] The relation of the hind-brain to micturition.
    Barrington, FJF
    [J]. BRAIN, 1921, 44 : 23 - 53
  • [3] The effect of lesions of the hind and mid-brain on micturition in the cat.
    Barrington, FJF
    [J]. QUARTERLY JOURNAL OF EXPERIMENTAL PHYSIOLOGY, 1925, 15 : 81 - 102
  • [4] BARRINGTON FJF, 1914, Q J EXP PHYSIOL CMS, V8, P33
  • [5] The standardization of terminology of female pelvic organ prolapse and pelvic floor dysfunction
    Bump, RC
    Mattiasson, A
    Bo, K
    Brubaker, LP
    DeLancey, JOL
    Klarskov, P
    Shull, BL
    Smith, ARB
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1996, 175 (01) : 10 - 17
  • [6] The urethrodetrusor facilitative reflex in women: Results of urethral perfusion studies
    Bump, RC
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2000, 182 (04) : 794 - 802
  • [7] GENUINE STRESS-INCONTINENCE AND DETRUSOR INSTABILITY - A REVIEW OF 200 PATIENTS
    CARDOZO, LD
    STANTON, SL
    [J]. BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1980, 87 (03): : 184 - 190
  • [8] DENNY-BROWN D., 1933, BRAIN, V56, P149
  • [9] FUKAYA Y, 1988, J NIPPON HINYOKIKA G, V79, P765
  • [10] Definition of overactive bladder and epidemiology of urinary incontinence
    Hampel, C
    Wienhold, D
    Benken, N
    Eggersmann, C
    Thuroff, JW
    [J]. UROLOGY, 1997, 50 (6A) : 4 - 14